Regeneron Pharmaceuticals (REGN) Notes Payables (2014 - 2020)
Regeneron Pharmaceuticals (REGN) recorded quarterly Notes Payables of $1.5 billion in Q2 2020, up 93650.0% quarter-over-quarter from $1.6 million in Q4 2015.
Regeneron Pharmaceuticals (REGN) Notes Payables (2014 - 2020) Analysis & Trends
Regeneron Pharmaceuticals' Notes Payables history runs 3 years deep, the most recent figure standing at $1.5 billion for Q2 2020.
- In Q2 2020, Notes Payables changed N/A year-over-year to $1.5 billion; the TTM figure through Jun 2020 stood at $1.5 billion (changed N/A YoY), while the FY2015 annual figure was $1.6 million, down 78.67% from the prior year.
- Notes Payables was $1.5 billion for Q2 2020 at Regeneron Pharmaceuticals, up from $1.6 million in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $1.5 billion in Q2 2020 to a low of $1.5 billion in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 1.50 Bn |
| Dec 31, 2015 | 1.60 Mn |
| Dec 31, 2014 | 7.50 Mn |